Use of E-Cigarettes May Hurt Efforts to Quit Smoking

Share this content:
Use of E-Cigarettes May Hurt Efforts to Quit Smoking
Use of E-Cigarettes May Hurt Efforts to Quit Smoking

WEDNESDAY, March 28, 2018 (HealthDay News) -- Among smokers who plan to quit after being discharged from the hospital, electronic cigarette (e-cigarette) users are less likely to abstain from tobacco at six months, compared to nonusers, according to a study published online March 27 in the Annals of Internal Medicine.

Nancy A. Rigotti, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted secondary data analysis of a randomized controlled trial in order to determine whether e-cigarette use after hospital discharge is associated with subsequent tobacco abstinence among 1,357 smokers who planned to quit and were assigned to either a tobacco treatment recommendation (control) or free tobacco treatment (intervention).

The researchers found that 28 percent of participants used an e-cigarette within three months after discharge. Based on 237 propensity score-matched pairs, e-cigarette users were less likely to abstain from tobacco use at six months compared to nonusers (10.1 versus 26.6 percent). There was variance in the association between e-cigarette use and quitting between intervention patients, who were given access to conventional treatment (7.7 versus 29.8 percent), and control patients, who received only treatment recommendations (12.0 versus 24.1 percent; P for interaction = 0.143).

"Additional study is needed to determine whether regular use of e-cigarettes aids or hinders smoking cessation," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »